- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01925495
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3
Middle Ear Pressure Regulation in Health and Disease/Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3
This is a study to determine if there are reflexes that detect changes in eardrum position or in the pressure of middle-ear gases and respond with changes in the ease by which the Eustachian tube is opened. The Eustachian tube is the normal tube that connects the middle ear to the nose. It is usually closed, but can be opened by contraction of 2 small muscles that surround the tube. If the Eustachian tube does not open frequently enough, the pressure in the middle ear will decrease, the eardrum will be pulled in toward the middle ear causing a hearing loss, and fluid will accumulate in the middle ear to try and stabilize its pressure. There is some evidence that the changes in eardrum position and middle-ear pressure when the Eustachian tube does not open frequently enough can be detected by the brain that, in turn, sends signals to the Eustachian tube and its muscles to make Eustachian tube opening easier. In this study, we will test this possibility.
Specifically, in 3 experiments done on 5 different days, we will move the eardrum in and out, apply different pressures to the middle ear, or change the composition of the gases in the middle ear while we measure how difficult it is to open the Eustachian tube by increasing middle-ear pressure or by measuring the "readiness" of the Eustachian tube muscles to contract and open the tube.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Adequate middle ear (ME) pressure-regulation, defined as the maintenance of a total ME pressure at approximately ambient levels, is required for normal hearing and to preserve ME health. The mechanism of ME pressure-regulation consists of two distinct components that affect total ME gas pressure: the bolus, total gradient driven exchange of gases between the ME and nasopharynx during active, transient Eustachian tube (ET) openings and the passive, partial-pressure gradient driven diffusive exchange of gases between the ME cavity and adjacent compartments. A large number of past studies have described the basic physiology of gas transfers through the ET in humans, but few have explored the possibility that physiological feedback mechanisms could modulate ET functional efficiency. However, there is an anatomic foundation to support feedback modulation of ET function and the results for some experiments in animals lend credibility to that possibility. Theoretically, the sensory components of possible feedback pathways could consist of stretch sensors in the tympanic membrane (TM; detecting position) and tensor tympani muscle (detecting tension) and/or chemo- (detecting gas pressures)/ baro- (detecting total pressure) receptors in the ME mucosa and effector components consisting of resting Tensor Veli Palatini muscle (mTVP) tonus and/or the extant ET periluminal pressure.
In this study, we explore 3 hypothesized stimulus-effector pairings in 10 otherwise healthy adult subjects with no history of significant ME disease and normal audiologic testing. Custom ear plugs will be made for use in Visits 2-6. The protocol includes 1 screening visit and 3 experiments requiring 5 experimental sessions of approximately 3-5 hours duration each done at a minimum interval of 2 days. Briefly, in Experiment 1 (Visit 2), ear canal pressure will be varied to change the position of the TM while simultaneously monitoring mTVP tonus by electromyography (EMG). Then, a unilateral ventilation tube (VT) inserted into the TM to allow access to the ME cavity. For Experiment 2, (Visits 3-5), the ME will be washed with physiologic, hypercarbic, and hyperoxic gas compositions (reference ME normal) while monitoring the ET periluminal tissue pressures measured as the ET resistance to gas flow. For Experiment 3 (Visit 6), total ME pressure will be varied while monitoring mTVP tonus by EMG. At the completion of Experiment 3, the VT will be removed and, then, the subjects will be followed weekly (Visits 7+) until documented healing of the TM at which time a standard audiologic assessment will be done. If the hypotheses are supported, selected activation of the feedback mechanisms would improve ET function and could be exploited as one component of a treatment protocol to improve ME pressure-regulation.
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Middle Ear Physiology Laboratory, University of PIttsburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Otherwise healthy adults aged 18 to 50 years, inclusive
- No history of significant ME disease
- No history of past ME surgeries
- Able to comprehend study risks and provide written Informed Consent
Exclusion Criteria:
- Have any chronic health problem
- Have ME fluid or otitis media (OM)at the time of presentation
- Have drainage through the tympanostomy tube at the time of testing
- Taking any prescription drug with the exception of those for birth control that would interfere with study per study MD
- Have a known or suspected allergy/adverse reaction to any of the study drugs use to prepare the tympanic membrane for ventilation tube insertion or the nasopharynx for EMG needle insertion
- Have a hearing threshold >15 dB or a >10 dB air-bone gap at any of the speech frequencies
- Pregnant or nursing
- Temporary exclusion: expected need for seasonal allergy med during study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: healthy adults
Experiment 1 -- variation of ear-canal pressure; Experiment 2 -- varied middle-ear gas compositions; Experiment 3 -- variation of middle-ear pressure
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
EMG activity
Time Frame: 2 visits (Visits 2 and 6), approximately 3 weeks apart
|
integrated EMG activity of tensor veli palatini muscle in response to changes in ear canal pressure and middle-ear pressure
|
2 visits (Visits 2 and 6), approximately 3 weeks apart
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
eustachian tube resistance
Time Frame: 3 visits, minimum 2 days apart
|
change in eustachian tube resistance in response to changes in middle ear gas composition
|
3 visits, minimum 2 days apart
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cuneyt M Alper, MD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PRO13050328
- P50DC007667 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Middle-ear Function
-
University of PittsburghCompletedMiddle-ear FunctionUnited States
-
University of PittsburghNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedMiddle-ear FunctionUnited States
-
Northwell HealthRecruitingEar Diseases | Middle Ear Disease | Pressure Injury | Eustachian Tube Dysfunction | Ear Barotrauma | Middle Ear; Injury | Middle Ear BarotraumaUnited States
-
Northwell HealthCompletedMiddle Ear Disease | Pressure Injury | Eustachian Tube Dysfunction | Ear Barotrauma | Middle Ear; Injury | Middle Ear BarotraumaUnited States
-
Sensoptic SACompletedOtosclerosis of Middle Ear | Cholesteatoma, Middle Ear | Disorder of Middle Ear
-
Karsten KönigsteinUniversity of Basel; QIAGEN Gaithersburg, IncCompletedAerobic Exercise | Endothelial Function | Middle-aged Adults Sedentary, Elevated CV-risk)Switzerland
-
Otonomy, Inc.CompletedBilateral Middle Ear EffusionUnited States
-
Otonomy, Inc.CompletedBilateral Middle Ear Effusion Requiring Tympanostomy Tube PlacementUnited States
-
University Hospital, MontpellierCompletedMiddle Ear CholesteatomaFrance
-
Prince of Songkla UniversityCompletedMiddle Ear CholesteatomaThailand
Clinical Trials on varied middle-ear pressure
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompletedChronic Serous Otitis Media, Simple or UnspecifiedFrance
-
Association Clinique Thérapeutique Infantile du...Recruiting
-
PhotoniCare, Inc.National Institute on Deafness and Other Communication Disorders (NIDCD); Carle... and other collaboratorsCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
PhotoniCare, Inc.University of Pittsburgh; National Institute on Deafness and Other Communication...Completed
-
Baylor College of MedicineActive, not recruitingOtitis Media | Middle Ear Infection | Ear InfectionUnited States
-
MED-EL Elektromedizinische Geräte GesmbHCompleted
-
Otologics LLCUnknownMixed Conductive and Sensorineural Hearing Loss, Bilateral
-
Yuinvent Innovations Ltd.UnknownOtitis Media With Effusion
-
Bezmialem Vakif UniversityCompleted